IUIS AAI Awards 2024 – Advanced Course


image_pdfimage_print

The IUIS Education (EDU) and Gender Equality and Career Development (GEC) Committees and the American Association of Immunologists (AAI) are pleased to announce their continued co-sponsorship of 4 awards for trainees from LMIC to attend the AAI Summer Introductory Course in Immunology.

 

The Advanced Course in Immunology will be held July 28- August 2, 2024 at The Westin Copley Place, Boston, MA.

A list of eligible countries can be found at the end of this announcement.

Preliminary information can be viewed on the AAI website (http://www.aai.org/Education/Courses). Complete information, including schedules and registration information, will be posted on the website.

The Advanced Course is directed towards advanced trainees and established scientists who wish to expand their knowledge of the field. Leading experts will present recent advances in the biology of the immune system and its role in health and disease. This is not an introductory course. All participants need to have a firm understanding of the principles of Immunology and experience conducting research.

AAI will provide registration and housing (up to 7 nights) for the 8 awardees. The IUIS will provide support for travel to the course and other associated expenses to a maximum of $2000 US. Additional expenses will be the responsibility of the attendee

The IUIS Education Committee will evaluate applications, perform an initial selection of awardees, and submit proposed candidates to AAI and the GEC committee for final review and approval. Once the selected candidates are informed, AAI will assist them with registration, and IUIS will assist with travel costs reimbursement. Both AAI and IUIS will send the selected candidates a letter of invitation.

Please note that per AAI policy, this should be an applicant’s first experience with AAI courses. Previous course attendees or IUIS/AAI awardees will not be considered. Preference will also be given to applicants who have NOT previously studied or had a substantial research experience in the USA or other high-income countries (e.g., Great Britain, Germany, France, Australia, etc.). Successful candidates must be conducting research and residing in LMIC (see eligible countries below); they cannot, for example, come from a LMIC but reside and work in a high-income country.

Application Deadline: Noon, US Central time on March 3, 2024

Only the candidates selected for awards will be notified, by March 22, 2024.

If you are not notified by these dates, we are unfortunately not able to offer you an award in 2024. Due to the substantial number of applications and limited staff, we are not able to provide individual feedback.

Click to View Eligible countries for applicants

Albania, Algeria, Angola, Argentina, Armenia, Azerbaijan, Bangladesh, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Chad, China, Colombia, Comoros, Republic of Congo, Costa Rica, Côte d’Ivoire, Djibouti, Dominica, Dominican Republic, Ecuador, Arab Republic of Egypt, El Salvador, Equatorial Guinea, Eritrea, Eswatini, Fiji, Gabon, The Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyz Republic, Lao PDR, Lesotho, Liberia, Madagascar, Malawi, Malaysia, Maldives, Marshall Islands, Mauritania, Mauritius, Mexico, Federated States of Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nepal, Niger, Nigeria, Pakistan, Palau, Papua New Guinea, Paraguay, Peru, Philippines, Rwanda, Samoa, São Tomé and Príncipe, Senegal, Sierra Leone, Solomon Islands, South Africa, Sri Lanka, St. Lucia, St. Vincent and the Grenadines, Suriname, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Türkiye, Turkmenistan, Tuvalu, Uganda, Uzbekistan, Vanuatu, Vietnam, West Bank and Gaza, Zambia.


Applications Closed

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids Foundation